Awarded: Nov 01, 2012
$1.45M over 3 years
In 2012, three projects received renewal grants totaling $1.45 million ($486,000 each) over three years to extend work that could significantly impact the understanding and treatment of sickle cell disease.
2012 ICRA Grantees
James E. Bradner, M.D.
Dana-Farber Cancer Institute
Project name: Targeted Derepression of Fetal Hemoglobin in Sickle Cell Disease
Patrick G. Gallagher, M.D., and Vincent P. Schulz, Ph.D.
Project name: Genomic and Functional Analyses of Erythrocyte Hydration Pathways as Modifiers in Sickle Cell Disease
Joel N. Hirschhorn, M.D., Ph.D., and Guillaume Lettre, Ph.D.
Broad Institute and Université de Montréal, Montreal Heart Institute
Project name: Translating Genetic Discoveries to Improve Sickle Cell Disease Prognosis and Treatment